4-methylthiobenzoic acid reduces cisplatin nephrotoxicity in rats without compromising anti-tumour activity
- 15 June 1991
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 41 (12) , 1997-2003
- https://doi.org/10.1016/0006-2952(91)90141-q
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Reversibility of binding of cisplatin-methionine in proteins by diethyldithiocarbamate or thiourea: a study with model adductsInorganic Chemistry, 1990
- High-dose cisplatin with diethyldithiocarbamate (DDTC) rescue therapy: preliminary pharmacologic observationsCancer Chemotherapy and Pharmacology, 1989
- The effects of co-administration of selenium and cis-platin (CDDP) on CDDP-induced toxicity and antitumour activityBritish Journal of Cancer, 1988
- Sodium thiosulfate fails to increase the therapeutic index of intravenously administered cis-diamminedichloroplatinum (II) in mice bearing murine and human tumorsCancer Chemotherapy and Pharmacology, 1988
- Effect of N-N'-diphenyl-p-phenylenediamine pretreatment on urinary enzyme excretion in cisplatin nephrotoxicity in rats.The Japanese Journal of Pharmacology, 1988
- Some procedures to reduce cis-platinum toxicity reduce antitumour activityCancer Treatment Reviews, 1987
- Cisplatin nephrotoxicity: insights into mechanismInternational Journal of Andrology, 1987
- Protection of antiproliferative effect of cis-diamminedichloroplatinum (II) by sodium thiosulfateCancer Chemotherapy and Pharmacology, 1986
- Inhibition of cis-diamminedichloroplatinum (II) ? induced renal toxicity in the ratCancer Chemotherapy and Pharmacology, 1986
- The nephrotoxicity of cisplatinLife Sciences, 1983